2010 General Meeting

Minutes of the Shareholders’ meeting held on 27 June 2011

• Dividend amount of 0.10 euro per share
• Optional dividend in cash or in shares from 20 July until 20 September 2011 included
• Issue price of the share: 50.64 euros

Press Release

Avignon, 11 July 2011 - Naturex, world leader in specialty plant-based natural ingredients, presents the minutes of the Shareholders’ meeting held on 27 June 2011 at 10am in Paris (Palais Brongniart).

This General meeting, chaired by Jacques Dikansky, ceo of the Company, was an opportunity to take a very positive assessment of last year, and to raise the first results of 2011 fiscal year as well as prospects Group's development.

A very active participation

During the General meeting, 4,335,595 shares (67.6% of capital) and 3,012,596 votes (59.3% of the voting rights) were represented, thus fulfilling the quorum requirements.

Approval of all resolutions subjected to shareholders

After reading the legal documents by the Board representatives and statutory auditors, shareholders voted the resolutions which were approved by a large majority, including statutory and consolidated accounts for 2010, and the renewal of the authorizations and delegations of power granted to the Board relating to capital operations.
The voting results are detailed below.

Option for the payment of the dividend in cash or in shares

The General meeting also approved the payment of a dividend amounting to 0.10 euro per share and proposes to shareholders to opt for the dividend payment in cash or shares between 20 July and 20 September 2011 included. If shareholders do not instruct their intermediaries on the shares OPTION before the end of the option period, they will receive the dividend in cash.

The issue price of the share given as payment for the dividend was set at 50.64 euros, corresponding to 90% of the average share price over the 20 trading days preceding the General meeting, less the net amount of the dividend.

If the dividend amount for which the stock option is chosen is not equivalent to a whole number of shares, shareholders have two options:

• The amount of shares can be rounded down to the nearest whole number and shareholders will receive a cash indemnification for the dividend that could not be exercised into shares;
• Shareholders can also opt to have the number of shares rounded up to the nearest whole number and in addition pay the difference in cash.

The "record date" is set for 19 July 2011 and the "ex-date" to 20 July 2011.
Payment of the dividend in cash and the admission of new shares on NYSE Euronext Paris will be held on 30 September 2011.

Euronext notice detailing the practical arrangements for this option will be available on 18 July 2011.

Details of voting on resolutions

• Resolution One - Ordinary
  Approval of the statutory accounts (Naturex S.A parent company)

• Adopted at 99.6% of the votes.

• Resolution Two - Ordinary
  Approval of the consolidated accounts (Group)

• Adopted at 99.6% of the votes.

• Resolution Three - Ordinary
  Allocation of the net result and setting of the dividend amount

• Adopted at 100% of the votes.

• Resolution Four - Ordinary
  Option for the payment of the dividend in cash or in shares

• Adopted at 99.8% of the votes.

• Resolution Five - Ordinary
  Report of the statutory auditors on regulated agreements and commitments and approval of these agreements

• Resolution adopted at 99.7% of the votes.
  
  Mr Dikansky and Mr Lambert were excluded from the vote of this resolution, given their common interest in these agreements and commitments.

• Resolution Six - Ordinary
  Ratification of the cooptation of Edmond de Rothschild Investment Partners

• Resolution adopted at 76.2% of the votes.

• Resolution Seven - Ordinary
  Appointment of Mrs Jacqueline Dikansky as a Director

• Resolution adopted as 73.9% of the votes.

• Resolution Eight - Ordinary
  Powers granted to the Board of Directors for the purposes of the Company purchasing its own shares within the framework of the provision of Article L.225-209 of the French commercial Code

• Resolution adopted at 89.7% of the votes.

• Resolution Nine - Extraordinary
  Powers granted to the Board of Directors for the purposes of cancelling the shares purchased by the Company within the framework of the provision of Article L.225-209 of the French commercial Code

• Resolution adopted at 99.7% of the votes.

• Resolution Ten - Extraordinary
  Powers granted to the Board of Directors to increase the capital through the incorporation of reserves, profits or premiums

• Resolution adopted at 99.7% of the votes.

• Resolution Eleven - Extraordinary
  Powers granted to the Board of Directors to carry out a capital increase through the issue of ordinary shares or securities providing access to the capital, with pre-emptive subscription rights

• Resolution adopted at 99.7% of the votes.

• Resolution Twelve - Extraordinary
  Powers granted to the Board of Directors to carry out a capital increase through the issue of ordinary shares and/or securities providing access to the capital, with revocation of pre-emptive subscription rights on a public share offer

• Resolution adopted at 77.6% of the votes.

• Resolution Thirteen - Extraordinary
  Powers granted to the Board of Directors to carry out a capital increase through the issue of ordinary shares and/or securities providing access to the capital, with revocation of pre-emptive subscription rights on a private investment offer

• Resolution adopted at 77.8% of the votes.

• Resolution Fourteen- Extraordinary
  Authorisation granted to the Board of Directors to increase the number of issues in the event of excess demand

• Resolution adopted at 86.1% of the votes.

• Resolution Fifteen- Extraordinary
  Authorisation granted to the Board of Directors to increase the Company's capital up to a maximum of 10% in order to remunerate contributions in kind of shares or securities providing access to the capital

• Resolution adopted at 92.6% of the votes.

• Resolution Sixteen- Extraordinary
  Powers granted to the Board of Directors to increase the capital through the issue of shares reserved for members in a company savings plan in application of Articles L.3332-18 et seq. of the French Labour Code

• Resolution adopted at 98.4% of the votes.

• Resolution Seventeen- Extraordinary
  Powers granted to the Board of Directors for the allocation of stock subscription and/or purchase options to pay staff employees and/or certain company officers

• Resolution adopted at 91.9% of the votes.

• Resolution Heighteen- Extraordinary
  Powers granted to the Board of Directors for the free allocation of shares to staff employees and/or certain company officers

• Resolution adopted at 83.1% of the votes.

• Resolution Nineteen- Extraordinary
  Amendment of section 8 of the Articles of Association relating to preference shares

• Resolution adopted at 69.3% of the votes.
  
  The company Natraceutical S.A, which owns 615,428 voting rights and holds preference shares, abstained in the vote given the subject of the resolution.

• Resolution Twenty - Ordinary
  Formalities

• Resolution adopted at 99.7% of the votes.

Documentation presented during the Shareholders’ meeting
The documents presented at the General meeting are available for download on the website www.naturex.fr, under section Investors > Documents 2011:

• The presentation broadcasted during the General meeting incorporating information on 2010 activities, 2011 outlook and development prospects as well as the draft of the resolutions submitted to shareholders’ approval;

• The Reference Document 2010 filed with the AMF on April 28, 2011 No. D.11.0389, including statutory and consolidated accounts for the year ended December 31, 2010, reports from Auditors and Chairman's report on the preparation and organization of the work of the Board and the internal control procedures settled, as well as the annual information document.

Hard copies of this document are also available free of charge from the Investor Relations department of the company.

• Upcoming publications
  - H1 revenue:: 26^th July 2011
  - H1 consolidated results : 31^st August 2011

You can receive all of NATUREX's FINANCIAL information free of charge by signing up on: www.naturex.com

NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996

Number of shares in the capital: 6,410,931 5,026,359 ordinary shares (ISIN FR0000054694) 1,384,572 preferred shares (ISIN FR0010833251) Naturex is part of the CAC Small and Gaïa Indexes. Naturex is eligible for the "long-only" DSS. MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP

About Naturex
Naturex is the global leader in specialty plant-based natural ingredients.

The Group is organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - and produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network of sales offices in 19 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).

Naturex’s sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its positioning on specific products which constitute niche markets, thanks to strong sourcing capacity and sustained Research & Development.

Contacts